Title : Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.

Pub. Date : 2012 Sep

PMID : 22706796






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this article is to report the first ever use of daclatasvir (DCV; also known as BMS-790052), a potent orally administered nonstructural 5A replication complex inhibitor, in combination with peginterferon alpha (PEG-IFNalpha) and ribavirin in an LT recipient. daclatasvir interferon alpha 1 Homo sapiens
2 The aim of this article is to report the first ever use of daclatasvir (DCV; also known as BMS-790052), a potent orally administered nonstructural 5A replication complex inhibitor, in combination with peginterferon alpha (PEG-IFNalpha) and ribavirin in an LT recipient. daclatasvir interferon alpha 1 Homo sapiens